Back
Panbela Therapeutics, Inc. 10K Form
Sell
5
PBLA
Panbela Therapeutics, Inc.
Last Price:
$0.0000
Seasonality Move:
-13.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PBLA News And Ratings
See the #1 stock for the next 7 days that we like better than PBLA
PBLA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-2.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-3.74 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -18.71680 |
|---|---|
| Net Income (TTM): | $-27.9M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Panbela Therapeutics, Inc. Earnings Forecast
Key Panbela Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 14 years have been positive in 8 years.
Panbela Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PBLA |
| Website: | panbela.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PBLA Technical Analysis vs Fundamental Analysis
Sell
5
Panbela Therapeutics, Inc. (PBLA)
is a Sell
Is Panbela Therapeutics, Inc. a Buy or a Sell?
-
Panbela Therapeutics, Inc. stock is rated a SellThe current Panbela Therapeutics, Inc. [PBLA] share price is $0.0011. The Score for PBLA is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.